Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing

被引:99
|
作者
Sarahrudi, Kambiz [1 ]
Thomas, Anita [2 ]
Mousavi, Mehdi [3 ]
Kaiser, Georg [1 ]
Koettstorfer, Julia [1 ]
Kecht, Mathias [1 ]
Hajdu, S. [1 ]
Aharinejad, S. [2 ]
机构
[1] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Ctr Anat & Cell Biol, Lab Cardiovasc Res, A-1090 Vienna, Austria
[3] Danube Hosp, Dept Traumatol & Sportstraumatol, A-1220 Vienna, Austria
基金
奥地利科学基金会;
关键词
TGF-beta; 1; Bone fracture; Non-union; Delayed union; Human; Serum concentration; BONE DEFECT; DISTRACTION OSTEOGENESIS; SYSTEMIC REGULATION; CELL-PROLIFERATION; SKELETAL INJURY; REPAIR; EXPRESSION; GROWTH-FACTOR-BETA-1; DIFFERENTIATION; CHONDROGENESIS;
D O I
10.1016/j.injury.2011.03.055
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Transforming growth factor-beta 1(TGF-beta 1) is a regulatory protein, involved in bone fracture healing. Circulating TGF-beta 1 levels have been reported to be a predictor of delayed bone healing and non-union, suggesting active relationship between tissue and circulating TGF-beta 1 in fracture healing. The purpose of this study was to analyse TGF-beta 1 local and serum concentrations in fracture healing to further contribute to the understanding of molecular regulation of fracture healing. Patients and methods: Serum samples of 113 patients with long bone fractures were collected over a period of 6 months following a standardised time schedule. TGF-beta 1 serum concentrations were measured using ELISA. Patients were assigned to 2 groups: Group 1 contained 103 patients with physiological healing. Group 2 contained 10 patients with impaired healing. Patients in both groups were matched. One patient of the group 2 had to be excluded because of missing match partner. In addition, fracture haematoma from 11 patients of group 1 was obtained to analyse local TGF-beta 1 concentrations. 33 volunteers donated serum which served as control. Results: TGF-beta 1 serum concentrations increased during the early healing period and were significantly higher in patients with physiological healing compared to controls (P = 0.04). Thereafter, it decreased continuously between weeks 2 and 8 and fell again after week 8. TGF-beta 1 serum concentrations in patients with physiological healing were significantly higher at week 24 compared to controls (P = 0.05). In non-unions, serum concentrations differed significantly from those of controls at week 6 (P = 0.01). No significant difference in between patients with physiological and impaired fracture healing was observed. Fracture haematoma contained significantly higher TGF-beta 1 concentrations than peripheral serum of the patients (P = 0.017). Conclusion: Elevated levels of TGF-beta 1 in haematoma and in serum after bone fracture especially during the entire healing process indicate its importance for fracture healing. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:833 / 837
页数:5
相关论文
共 50 条
  • [41] TRANSCRIPTIONAL REGULATION OF TRANSFORMING GROWTH FACTOR-BETA(1) (TGF-BETA(1)) PROMOTER BY CALCINEURIN
    AHUJA, SS
    BALOW, JE
    BOUMPAS, DT
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 687 - 687
  • [42] Transforming growth factor-beta 1, (TGF-beta 1) in patients with amyotrophic lateral sclerosis
    Ilzecka, J
    Stelmasiak, Z
    Dobosz, B
    [J]. CYTOKINE, 2002, 20 (05) : 239 - 243
  • [43] Glucose-mediated regulation of transforming growth factor-beta (TGF-β) and TGF-β receptors in human retinal endothelial cells
    Pascal, MM
    Forrester, JV
    Knott, RM
    [J]. CURRENT EYE RESEARCH, 1999, 19 (02) : 162 - 170
  • [44] TGF-β1 as a pathophysiological factor in fracture healing
    Zimmermann, G.
    Moghaddam, A.
    Reumann, M.
    Wangler, B.
    Breier, L.
    Wentzensen, A.
    Henle, P.
    Weiss, S.
    [J]. UNFALLCHIRURG, 2007, 110 (02): : 130 - 136
  • [45] Transforming growth factor-beta 1 (TGF-β1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures
    Zhang, H
    Aronow, MS
    Gronowicz, GA
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 75A (01) : 98 - 105
  • [46] Transforming growth factor beta (TGF-β) isoforms in wound healing and fibrosis
    Lichtman, Michael K.
    Otero-Vinas, Marta
    Falanga, Vincent
    [J]. WOUND REPAIR AND REGENERATION, 2016, 24 (02) : 215 - 222
  • [47] Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
    Mirzaei, Sepideh
    Paskeh, Mahshid Deldar Abad
    Saghari, Yalda
    Zarrabi, Ali
    Hamblin, Michael R.
    Entezari, Maliheh
    Hashemi, Mehrdad
    Aref, Amir Reza
    Hushmandi, Kiavash
    Kumar, Alan Prem
    Rabiee, Navid
    Ashrafizadeh, Milad
    Samarghandian, Saeed
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 206 : 435 - 452
  • [48] Release of transforming growth factor-beta (TGF-β) by apoptotic T cells.
    Chen, WJ
    Frank, ME
    Jin, WW
    Wahl, SM
    [J]. FASEB JOURNAL, 2000, 14 (06): : A1225 - A1225
  • [49] Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
    Baba, Abdul Basit
    Rah, Bilal
    Bhat, Gh Rasool
    Mushtaq, Ifra
    Parveen, Sabra
    Hassan, Rukhsana
    Zargar, Mahrukh Hameed
    Afroze, Dil
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [50] Effects of transforming growth factor-beta (TGF-β1) on satellite cell activation and survival during oxidative stress
    Christopher R. Rathbone
    Keitaro Yamanouchi
    Xiaoyu K. Chen
    Cedrine J. Nevoret-Bell
    Robert P. Rhoads
    Ronald E. Allen
    [J]. Journal of Muscle Research and Cell Motility, 2011, 32 : 99 - 109